Histone deacetylase inhibition as a mechanism for the therapeutic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors) in follicular lymphoma.

Overview

authors

Barker, Christopher A

Yahalom, Joachim

publication date

June 21, 2010

published in

Journal of clinical oncology : official journal of the American Society of Clinical Oncology Journal

Research

keywords

Antibodies, Monoclonal
Antineoplastic Agents
Histone Deacetylase Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lymphoma, Follicular

Identity

Scopus Document Identifier

77956256698

Digital Object Identifier (DOI)

10.1200/JCO.2010.28.9488

PubMed ID

20566995

Additional Document Info

has global citation frequency

4

volume

28

issue

24